Searched over 200M research papers for "heart chambers"
10 papers analyzed
These studies suggest that the heart chambers develop from a tubular heart tube with distinct transcriptional programs and gene expressions, and their specific functions and characteristics are critical for understanding heart development, disease, and potential therapeutic targets.
19 papers analyzed
The formation of the four-chambered heart in vertebrates is a complex process influenced by evolutionary and developmental factors. Initially, the embryonic heart is a simple tubular structure composed of pacemaker-like cells that generate unidirectional contraction waves. As development progresses, ventricular chambers form ventrally and atrial chambers dorsally, characterized by high proliferative activity and well-developed muscle cells. This transformation from a tubular to a four-chambered heart involves intricate molecular pathways and evolutionary adaptations, including the role of retinoic acid (RA) signaling in patterning cardiac segments.
Chamber formation in the mammalian heart follows a two-step model. First, a linear heart tube forms with primary myocardium showing polarity in gene expression along its axes. Subsequently, specialized ventricular myocardium develops on the ventral surface, while atrial myocardium forms on the laterodorsal surfaces. This process is regulated by distinct transcriptional programs, with genes like Hand1, Irx4, and Tbx5 playing crucial roles in compartmentalization. Irx4, in particular, is essential for ventricle-specific gene expression, regulating myosin isoforms to establish chamber-specific functions.
The heart's chambers exhibit unique gene expression patterns critical for their specialized functions. Genome-wide transcriptional profiling has identified numerous genes involved in cardiac development and function, including LIM proteins, homeobox proteins, and myosins. These genes contribute to the structural and functional specialization of each chamber, with distinct expression patterns observed in atria and ventricles. Additionally, mechano-sensitive ion channels (MSC) show chamber-preferential expression, indicating their role in mechano-transduction and cardiac diseases.
Metabolic profiling reveals that the atria and ventricles have distinct metabolic patterns. Ventricles, which function as high-pressure chambers, exhibit higher levels of high-energy phosphates and tricarboxylic acid cycle intermediates compared to atria. Transcriptomic analysis further highlights differences between failing and nonfailing hearts, with immune system signaling being a hallmark of all chambers in failing hearts. These findings suggest that metabolic and transcriptomic profiling can provide insights into the pathophysiology of heart diseases.
Technological advancements in echocardiography and cardiac computed tomography (CT) have improved the quantification and analysis of heart chambers. Updated guidelines from the American Society of Echocardiography and the European Association of Cardiovascular Imaging provide normal values for all four chambers, incorporating three-dimensional echocardiography and myocardial deformation. Additionally, automatic segmentation systems using advanced algorithms enable efficient and accurate analysis of cardiac CT volumes, facilitating better diagnosis and treatment planning.
The development and function of heart chambers are governed by complex genetic, molecular, and evolutionary mechanisms. Understanding these processes through advanced imaging, gene expression profiling, and metabolic analysis provides valuable insights into cardiac health and disease. Future research in this area holds the potential to uncover novel therapeutic targets and improve clinical outcomes for heart disease patients.
Most relevant research papers on this topic